Blockade of Bradykinin B2Receptors Prevents the Increase in Capillary Density Induced by Chronic Angiotensin-Converting Enzyme Inhibitor Treatment in Stroke-Prone Spontaneously Hypertensive Rats
Authors:
- 1 January 1997
- journal article
- other
- Published by Wolters Kluwer Health in Hypertension
- Vol. 29 (1) , 478-482
Abstract
We investigated the mechanism of action of the ACE inhibitor-induced increase in cardiac capillary length density. Stroke-prone spontaneously hypertensive rats were treated prenatally and up to the age of 20 weeks with the ACE inhibitor ramipril (0.01 and 1 mg/kg per day PO) and the AT1 receptor antagonist losartan (30 mg/kg per day PO). The contribution of endogenous bradykinin potentiation to the ACE inhibitor actions was assessed by cotreatment with the bradykinin B2-receptor antagonist Icatibant (0.5 mg/kg per day, SC via osmotic minipumps) from 6 to 20 weeks of age. At the end of the treatment period, cardiac capillary length density was measured stereologically using the orientator method. The development of hypertension and left ventricular hypertrophy was prevented by high- but not low-dose ramipril and was not affected by chronic bradykinin B2-receptor blockade. Low- and high-dose ramipril significantly increased cardiac capillary length density (3577±279, n=11 and 3988±300 mm/mm3; n=10;P<.05) compared with vehicle-treated animals (2935±137 mm/mm3; n=13). These effects were abolished by chronic bradykinin B2-receptor blockade. The bradykinin antagonist alone was without effect on cardiac capillary length density. Losartan prevented hypertension and left ventricular hypertrophy but did not significantly alter cardiac capillary length density (3429±309 mm/mm3; n=7). Our results demonstrate that chronic ACE inhibitor treatment can increase cardiac capillary length density in stroke-prone spontaneously hypertensive rats independently of a reduction in blood pressure or left ventricular hypertrophy. This effect is related to the ACE inhibitor-induced potentiation of endogenous bradykinin since it was prevented by chronic bradykinin B2-receptor blockade and was not observed following antihypertensive treatment with the AT1-receptor antagonist losartan.Keywords
This publication has 18 references indexed in Scilit:
- The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.Journal of Clinical Investigation, 1995
- Potential effects of bradykinin on myocardial capillary growth after angiotensin converting enzyme inhibitionExpert Opinion on Investigational Drugs, 1994
- Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin.Hypertension, 1994
- Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphate.Hypertension, 1993
- Spirapril Prevents Left Ventricular Hypertrophy, Decreases Myocardial Damage and Promotes Angiogenesis in Spontaneously Hypertensive RatsJournal of Cardiovascular Pharmacology, 1993
- Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries.Hypertension, 1992
- Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril.Hypertension, 1992
- Activation of DNA synthesis and inositol-phosphate turnover in coronary venular endothelial cells exposed to bradykininPharmacological Research, 1992
- Capillary neoformation in the rat heart-stereological studies on papillary muscles in hypertrophy and physiologic growthBasic Research in Cardiology, 1990
- Growth of capillaries and myocardial cells in the normal rat heartJournal of Molecular and Cellular Cardiology, 1987